Physician

Charles Blay, D.O.

According to 2025 Medicare claims, Charles Blay, D.O. (NPI: 1245761634) practices internal medicine in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is WOODLANDS MEDICAL SPECIALISTS P A (NPI: 1225274772; TIN: 261802830) and primary practice location at 32503-2339. Blay is affiliated with the Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Blay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 546 traditional Medicare patients, billed 15,367 HCPCS/CPT codes, and received $411,916 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,432 prescription claims across 807 beneficiaries totaling $971,460 in drug costs, led by Ozempic (Semaglutide). DME data shows 380 claims. Open Payments data shows 142 records totaling $2,448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $47,915 to $411,916. Similarly, Part D prescription costs have moved sharply higher in recent years, from $871 to $971,460. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	134	979	$47,915
2021	927	8,835	$284,421
2022	492	7,429	$283,807
2023	485	12,537	$407,612
2024	546	15,367	$411,916

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	16	$871
2019	12	20	$508
2020	130	438	$33,599
2021	477	5,106	$477,840
2022	606	6,740	$667,887
2023	729	7,371	$921,888
2024	807	8,432	$971,460

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	43	$1,239
2022	N/R	96	$3,492
2023	78	354	$27,072
2024	104	380	$39,568

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	348	348	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	453	882	$86
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	259	2,164	$46
G0442	Annual alcohol misuse screening, 5 to 15 minutes	358	358	$18
G0444	Annual depression screening, 5 to 15 minutes	357	357	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	111	4,762	$142,056
Jardiance	Empagliflozin	81	5,302	$94,077
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	2,880	$64,456
Eliquis	Apixaban	62	3,200	$61,852
Mounjaro	Tirzepatide	43	1,552	$53,099

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	13	57	$29,196
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	27	$2,501
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	14	37	$1,956
A7031	Face mask interface, replacement for full face mask, each	N	N/R	16	$1,144
A7030	Full face mask used with positive airway pressure device, each	N	N/R	14	$1,065

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$2,448	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Blay, D.O.?

Tedicare shows public-source Medicare data for Charles Blay, D.O. (NPI 1245761634), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Blay, D.O. have ACO affiliation data?

Charles Blay, D.O. is shown with ACO affiliation data for Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to Charles Blay, D.O.?

Charles Blay, D.O. is linked to WOODLANDS MEDICAL SPECIALISTS P A (billing NPI 1225274772) in the available physician profile data.

Does Charles Blay, D.O. have Open Payments data?

Charles Blay, D.O. has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.